Related references
Note: Only part of the references are listed.Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma
Longyang Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells
Zheqing Cui et al.
BMC CANCER (2019)
Effects of miRNA-342-3p in modulating Hedgehog signaling pathway of human umbilical cord mesenchymal stem cells by down-regulating Sufu
Ying Qing et al.
ORAL DISEASES (2019)
MiR-342-3p inhibits cell migration and invasion through suppressing forkhead box protein Q1 in ovarian carcinoma
Changhe Wang et al.
ANTI-CANCER DRUGS (2019)
miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer
Xiaofeng Xue et al.
CANCER LETTERS (2018)
miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect
Wenpeng Liu et al.
ONCOTARGETS AND THERAPY (2018)
miR-342-3p promotes osteogenic differentiation via targeting ATF3
Yawei Han et al.
FEBS LETTERS (2018)
MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis
Qingxin Zhou et al.
CELL DEATH & DISEASE (2016)
The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update
Waseem Ahmad Siddiqui et al.
ARCHIVES OF TOXICOLOGY (2015)
miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells
Xiao Xie et al.
TUMOR BIOLOGY (2015)
MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy
Esteban A. Orellana et al.
CANCERS (2015)
Author reply: the role of academic health centres to inform evidence-based integrative oncology practice
David H. Gorski
NATURE REVIEWS CANCER (2015)
Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells
Chandrani Achari et al.
BMC CANCER (2014)
The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets
Steven L. Wood et al.
CANCER TREATMENT REVIEWS (2014)
miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer
Xin Yan et al.
MOLECULAR CANCER (2014)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
MicroRNA regulation of core apoptosis pathways in cancer
Raquel T. Lima et al.
EUROPEAN JOURNAL OF CANCER (2011)
microRNAs and lung cancer: tumors and 22-mers (vol 29, pg 109, 2010).
Liqin Du et al.
CANCER AND METASTASIS REVIEWS (2010)
Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype
A Worth et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
N Yanaihara et al.
CANCER CELL (2006)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
A microRNA array reveals extensive regulation of microRNAs during brain development
AM Krichevsky et al.
RNA (2003)
Fas ligand-mediated apoptosis in degenerative disorders of the brain
DW Ethell et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2003)
Share Paper
